Download presentation
Presentation is loading. Please wait.
1
Local anesthetic systemic toxicity ( LAST)
Dr. S. Parthasarathy MD, DA, DNB, Dip Diab.MD ,DCA, Dip software based statistics, PhD (physiology) FICA
2
What is it ?? Allergic reactions
Tissue toxicity – TNS, lignocaine spinal Probably blockade of calcium channels ---- LAST – systemic
3
Allergy True immunologic reactions to LAs are generally rare.
True allergic reactions to preservative-free amide-type local anesthetics are so rare. True anaphylaxis appears more common with ester LAs that are metabolized directly to PABA Accidental intravenous injections are often misdiagnosed as allergic reactions. Some patients may react to preservatives, such as methylparaben, included with LAs.
4
History 1880 = cocaine invented and toxicity described
1960 = bupivacaine discovered = Later levo bupi and ropi invented Lipid emulsion for LAST ( 0.1 in 1000)
5
Mechanisms Cardiovascular effects are caused by blockade of cardiac VASCs and K+ channels. Levobupivacaine and ropivacaine are thought less likely to interact with cardiac VASCs. Possible calcium channel block Mitochondrial dysfunction Convulsions may be caused by the blockade of GABA A receptors in the CNS
6
Fast in fast out -- lignocaine
Fast in slow out --- bupivacaine ( dissociation constant – more with bupi )
7
Order of toxicity IVRA Intercostal Caudal Epidural Brachial plexus
Sciatic IVRA
8
Why difference Age – extremes Additive Speed Which drug
Concurrent illness Concurrent drugs Site Bupi – 2-3 mg / kg Ligno – 4-5 mg/kg Ligno with adrenaline 7 mg / kg But beware of combinations – additive toxicity
9
Toxicity Cocaine worst Tetracaine Bupivacaine L. bupi Ropi Mepi Ligno
Prilo 2– chlorprocaine least
10
Moving towards safer molecules ?
11
Pick up here
12
Starts from to (auditory changes, circum oral numbness,
metallic taste, and agitation), central nervous system (CNS) findings (seizure, coma, respiratory arrest) Inhibitory neurons first !!- so seizures cardiovascular events (hypertension, hypotension, tachycardia, bradycardia, ventricular arrhythmias, cardiac arrest)
13
Injection of lignocaine in the brain induced arrhythmias
Cause – for cardiac effects – CNS depression hypotension and rhythm disturbances . Hypercarbia , acidosis enhance CNS toxicity
14
Differential diagnosis
Vasovagal High spinal Total spinal Concomitant disease - High epinephrine dosage
15
Prevention is the essence
Management Prevention is the essence
16
Check dose of local and epinephrine
USG Check dose of local and epinephrine Effective dose in increments – catheters ?? Aspirate frequently Discard bloody locals Monitor CVS and IV access Talk with the patient Stop injecting Negative aspiration not foolproof because probe will compress the vein Hepatic or renal disease
17
(CC:CNS ratio 2 : 7.1 for the two LA)
Convulsion Lethality lignocaine 22 mg/kg 76mg/kg Bupivacaine 5mg/kg 20mg/kg
18
Are they clinically relevant ??
the reduced toxic potential of the two pure left-isomers supports their use in those clinical situations in which the risk of systemic toxicity related to either overdosing or unwanted intravascular injection is high, such as during epidural or peripheral nerve blocks.
19
Treatment Convulsions Thiopentone 1-3 mg/kg Diazepam - 0.15 mg/kg
Midazolam – 0.1 mg / kg Less doses – because thio itself is myocardial depressant .propofol may cause more hypotension Benzodiazepines also decrease arrhythmias
20
Arrhythmias Better to use calcium channel blockers
Valproate ( fits and rhythm disturbances ) Phenytoin Bretylium NO XYLOCAINE
21
Resuscitation CPB ? Airway- breathing- circulation Oxygen - 100 %
Ventilation Special Vasopressin ? GIK Amiodarone if preliminary resuscitation fails ---- CPB ?
22
Lipid emulsion Bolus of intralipid – 20 % - 1.5 ml/kg – 1 minute
Infusion – 0.25 ml /kg/minute Chest compressions – lipid should circulate Can increase to 0.5 ml/kg/min Maximum of 8 ml/kg ml /kg – guidelines vary
23
Mechanism Direct Sink theory – sticks to lipid soluble LA and get rid of the drug out of the tissue Indirect Overrides mitochondrial translocase from the LA
24
Predominant CNS changes – anticonvulsants
Predominant CVS changes – Go for intra lipid early
25
Prilocaine More than 600 mg
Associated with – o toluidine and methemoglobinemia IV methylene blue is the treatment
27
Summary Intercostal , IVRA Toxic doses Which local anesthetic
Symptoms and DD Prevention Treatment Lipid emulsion or anticonvulsants -
28
Thank you all
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.